| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |